With 15 Nanomedicine related patents published between 2002 and 2022, Johnson & Johnson holds the most number of Nanomedicine patents in Hong Kong, of which 60.0% was contributed by its subsidiary Johnson & Johnson Vision Care Inc.
The second largest number of Nanomedicine related patents were published by Nanoco Group Plc with 10 patents. The third largest number of Nanomedicine related patents were published by Otsuka Holdings Co Ltd with 10 patents, of which 50.0% was contributed by its subsidiary Otsuka Pharmaceutical Co Ltd. The fourth largest number of Nanomedicine related patents were published by Bristol-Myers Squibb Co with 9 patents, of which 88.9% was contributed by Abraxis BioScience, LLC. The fifth largest number of Nanomedicine related patents were published by Cambrios Technologies Corp with 7 patents.
The top five patent holders, i.e., Johnson & Johnson, Nanoco Group Plc, Otsuka Holdings Co Ltd, Bristol-Myers Squibb Co, and Cambrios Technologies Corp, together held 51 Nanomedicine patents during the period.
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward